Kurma Partners — 2021 Investments

5 investments dated 2021 · listed companies and verified rows first · show all

Corteriapharmacorteriapharma.com inSeed · Dec 2021 · $14M✓ verified

Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity.

BiotechDigital HealthHealthtechLongevity

Philip Janiakin Marie-Laure Ozoux inRégis OlivierinFrancesca C. LawsonMark KowalaEleonore Jouannyin

Co-investorsFountain Healthcare Partners Jeito Capital OrbiMed V-Bio Ventures Omnes Capital Invivo Capital Partners +1 more

Step Pharmastep-ph.com inMar 2021✓ verified

Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.

BiotechDeep TechMedical DevicesSaint-Genis-Pouilly, FR

Alain Fischer(Founding Scientist)

Co-investorsHadean Ventures Bpifrance Pontifax Venture Capital Sunstone Capital V-Bio Ventures

Arkhnarkhn.orgSeries A · May 2021 · $5M

Co-investorsNewfund Capital

Sunrisesunrise.aiSeed · Dec 2021 · $7M

Sunrise AI designs, deploys, and operates custom AI systems inside client businesses, connecting to their proprietary data and workflows to build an "AI operating layer" starting with a single high-impact workflow.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsAI Fund

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Emergence Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.